Clinical Trial Update: Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2) [NA]

View source ↗

Summary

A clinical trial update shows a radioimmunotherapy study for Glioblastoma is currently recruiting, sponsored by IRCCS San Raffaele.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Glioblastoma | NA | Status: RECRUITING